V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240007087 | 240004431 | 1.66 | 57 | Curative (C) | 2015-08-06 | 2015-08-06 | ALCL ALCL 99 Closed Pre Phase | N | N | 240032484 | NOT MATCHED |
| 240007088 | 240004432 | 1.72 | null | Palliative (P) | 2016-01-06 | 2016-01-14 | Bevacizumab+Carbo+Pacliaxel | 02 | N | 240032485 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007089 | 240004433 | 1.71 | null | Palliative (P) | 2014-12-21 | 2014-12-21 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240032487 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007090 | 240004433 | null | null | Palliative (P) | 2014-06-03 | 2014-06-05 | Hydroxycarbamide | N | N | 240032487 | HYDROXYCARBAMIDE |
| 240007091 | 240004434 | 1.62 | 118.8 | null | null | 2018-10-02 | Carboplatin AUC 6 - 10 | 2 | N | 240032492 | CARBOPLATIN |
| 240007092 | 240010481 | null | 55.1 | null | 2016-10-25 | 2016-11-05 | Bendamustine +/- Prednisolone | N | Y | 240032493 | BENDAMUSTINE |
| 240007093 | 240004435 | 1.66 | null | Palliative (P) | 2014-04-15 | 2014-05-04 | ALCL ALCL 99 Closed Pre Phase | null | N | 240032496 | NOT MATCHED |
| 240007094 | 240004436 | 1.74 | 65.1 | Palliative (P) | 2015-11-06 | 2015-11-15 | Bevacizumab+Carbo+Pacliaxel | N | null | 240032498 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007095 | 240010482 | null | null | Curative (C) | 2015-09-03 | 2015-09-03 | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB | null | null | 240032504 | NOT MATCHED |
| 240007096 | 240004437 | 1.85 | 60 | Curative (C) | null | 2015-11-29 | Bendamustine +/- Prednisolone | null | null | 240032509 | BENDAMUSTINE |
| 240007097 | 240004437 | 1.64 | 96 | Palliative (P) | 2015-10-26 | 2015-10-29 | Bevacizumab+Carbo+Pacliaxel | N | N | 240032509 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007098 | 240004437 | 1.85 | 69.9 | Curative (C) | 2013-02-25 | 2013-02-26 | DA 3 + 10 | N | N | 240032509 | DA |
| 240007099 | 240004438 | 1.6 | 89 | Curative (C) | 2017-03-12 | 2017-03-12 | Carboplatin AUC 6 - 10 | N | Y | 240032513 | CARBOPLATIN |
| 240007100 | 240004439 | 1.66 | 55.7 | Curative (C) | 2017-08-08 | 2017-08-08 | DA 3 + 10 | 2 | N | 240032517 | DA |
| 240007101 | 240004440 | 1.64 | 60 | Palliative (P) | 2013-07-23 | 2013-07-23 | Bevacizumab+Carbo+Pacliaxel | Y | Y | 240032520 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007102 | 240004441 | 1.69 | 61.9 | null | null | 2016-05-13 | null | N | N | 240032521 | NOT MATCHED |
| 240007103 | 240004441 | 0 | 110.6 | Curative (C) | 2016-09-30 | 2016-10-07 | Carboplatin AUC 6 - 10 | N | N | 240032521 | CARBOPLATIN |
| 240007104 | 240004442 | 1.73 | 63 | Disease modification (D) | 2013-09-15 | 2014-03-10 | Hydroxycarbamide | N | N | 240032523 | HYDROXYCARBAMIDE |
| 240007105 | 240004442 | 1.84 | 78 | null | 2015-12-01 | 2015-12-01 | Chlorambucil | N | N | 240032523 | CHLORAMBUCIL |
| 240007106 | 240004443 | 1.66 | 78 | null | 2017-04-26 | 2017-05-26 | Carboplatin AUC 6 - 10 | N | N | 240032537 | CARBOPLATIN |
| 240007107 | 240004444 | null | 83.3 | null | 2014-01-30 | 2014-02-09 | Trial Unspecified | 2 | N | 240032542 | TRIAL |
| 240007108 | 240010486 | 1.55 | 77.8 | Disease modification (D) | 2018-01-06 | 2018-01-06 | Chlorambucil | N | N | 240032543 | CHLORAMBUCIL |
| 240007109 | 240004445 | 1.57 | 64.95 | Palliative (P) | null | 2014-08-11 | R Chlorambucil | N | N | 240032546 | CHLORAMBUCIL + RITUXIMAB |
| 240007110 | 240004445 | 1.74 | null | Adjuvant (A) | null | 2015-06-14 | Bendamustine +/- Prednisolone | 02 | N | 240032546 | BENDAMUSTINE |
| 240007111 | 240004446 | 1.63 | 58.2 | Curative (C) | 2018-02-11 | 2018-02-17 | INTERLACE TRIAL | 02 | N | 240032552 | INTERLACE TRIAL |
| 240007112 | 240004447 | 0 | 65.6 | Palliative (P) | 2015-06-08 | 2015-06-09 | Hydroxycarbamide | 2 | N | 240032553 | HYDROXYCARBAMIDE |
| 240007113 | 240004447 | 1.45 | 70 | Curative (C) | null | 2013-01-18 | DA 3 + 10 | 02 | N | 240032553 | DA |
| 240007114 | 240004447 | null | 52.7 | Curative (C) | 2017-06-26 | 2017-07-12 | LI-1 TRIAL | N | N | 240032553 | TRIAL |
| 240007115 | 240004447 | 1.67 | 117 | Disease modification (D) | 2017-03-29 | 2017-03-30 | R Chlorambucil | 2 | N | 240032553 | CHLORAMBUCIL + RITUXIMAB |
| 240007116 | 240004448 | 1.58 | 84 | Palliative (P) | 2016-11-15 | 2016-11-15 | Hydroxycarbamide | 2 | N | 240032567 | HYDROXYCARBAMIDE |
| 240007117 | 240004448 | 0 | 70 | Curative (C) | 2015-08-14 | 2015-08-14 | INTERLACE TRIAL | 02 | N | 240032567 | INTERLACE TRIAL |
| 240007118 | 240004448 | null | null | Not known (9) | 2015-01-06 | 2015-01-08 | Bendamustine + prednisolone | null | null | 240032567 | BENDAMUSTINE |
| 240007119 | 240004449 | null | 59 | Curative (C) | 2015-06-02 | 2015-06-05 | DA | N | N | 240032573 | DA |
| 240007120 | 240004450 | 1.73 | 87.1 | Palliative (P) | 2017-05-25 | 2017-05-25 | Hydroxycarbamide | N | N | 240032575 | HYDROXYCARBAMIDE |
| 240007121 | 240004450 | null | 53.2 | Palliative (P) | 2013-06-24 | 2013-06-24 | Bevacizumab+Carbo+Pacliaxel | N | N | 240032575 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007122 | 240004450 | 1.67 | 55 | Adjuvant (A) | null | 2015-09-06 | Chlorambucil | N | N | 240032575 | CHLORAMBUCIL |
| 240007123 | 240014905 | null | 60.5 | Disease modification (D) | 2016-12-12 | 2016-12-12 | Hydroxycarbamide | N | Y | 240032582 | HYDROXYCARBAMIDE |
| 240007124 | 240004451 | 1.45 | 134 | Curative (C) | 2017-05-31 | 2017-05-31 | Trial Unspecified | N | N | 240032586 | TRIAL |
| 240007125 | 240004452 | null | 80 | Palliative (P) | 2013-05-11 | 2013-05-11 | Bendamustine +/- Prednisolone | null | null | 240032590 | BENDAMUSTINE |
| 240007128 | 240004454 | 1.68 | 70.3 | Palliative (P) | 2014-11-28 | 2015-01-24 | Chlorambucil | N | N | 240032595 | CHLORAMBUCIL |
| 240007129 | 240010492 | 1.53 | 78 | Curative (C) | 2017-04-17 | 2017-04-17 | DA 3 + 10 | Y | N | 240032600 | DA |
| 240007130 | 240010492 | 1.64 | 79.5 | Palliative (P) | 2016-11-29 | 2016-11-30 | CARBOPLATIN + ETOPOSIDE | 02 | N | 240032600 | CARBOPLATIN + ETOPOSIDE |
| 240007131 | 240004455 | 1.84 | 74.6 | Curative (C) | 2013-12-04 | 2013-12-07 | Trial Unspecified | N | N | 240032605 | TRIAL |
| 240007132 | 240004455 | 0 | 60 | Curative (C) | 2017-09-23 | 2017-10-02 | INTERLACE TRIAL | N | N | 240032605 | INTERLACE TRIAL |
| 240007133 | 240004455 | 1.5 | 110 | 5 | 2015-04-07 | 2015-11-11 | CHLORAMBUCIL + RITUXIMAB | N | N | 240032605 | CHLORAMBUCIL + RITUXIMAB |
| 240007134 | 240004455 | 1.78 | 97 | Curative (C) | 2016-12-01 | 2016-12-07 | ALCL ALCL 99 Closed Pre Phase | N | N | 240032605 | NOT MATCHED |
| 240007135 | 240004456 | 1.83 | 69.5 | null | null | 2015-09-22 | R Chlorambucil | N | N | 240032619 | CHLORAMBUCIL + RITUXIMAB |
| 240007136 | 240004456 | 1.53 | 0 | Curative (C) | 2013-07-09 | 2013-07-11 | INTERLACE TRIAL | 01 | N | 240032619 | INTERLACE TRIAL |
| 240007137 | 240004457 | 1.5 | 60.35 | Disease modification (D) | 2013-08-05 | 2013-08-08 | CHLORAMBUCIL + RITUXIMAB | null | null | 240032625 | CHLORAMBUCIL + RITUXIMAB |
| 240007138 | 240004458 | null | 71 | Curative (C) | 2018-01-11 | 2018-02-02 | null | N | N | 240032633 | NOT MATCHED |